| [1] |
刘子轩, 霍 清, 孙雅煊, 等. 抑郁症动物模型的建立及评价方法研究进展 [J]. 中国实验动物学报, 2025,33(02):93-102.
|
| [2] |
Kendler KS, Gardner CO. Dependent stressful life events and prior depressive episodes in the prediction of major depression: the problem of causal inference in psychiatric epidemiology[J]. Arch Gen Psychiatry, 2010, 67(11): 1120-7. doi:10.1001/archgenpsychiatry.2010.136
|
| [3] |
Licinio J, Wong ML. Advances in depression research: second special issue, 2020, with highlights on biological mechanisms, clinical features, co-morbidity, genetics, imaging, and treatment[J]. Mol Psychiatry, 2020, 25(7): 1356-60. doi:10.1038/s41380-020-0798-1
|
| [4] |
Correia AS, Vale N. Tryptophan metabolism in depression: a narrative review with a focus on serotonin and kynurenine pathways[J]. Int J Mol Sci, 2022, 23(15): 8493. doi:10.3390/ijms23158493
|
| [5] |
Dell’Osso L, Carmassi C, Mucci F, et al. Depression, serotonin and tryptophan[J]. Curr Pharm Des, 2016, 22(8): 949-54. doi:10.2174/1381612822666151214104826
|
| [6] |
Kouba BR, Gil-Mohapel J, Rodrigues ALS. NLRP3 inflammasome: from pathophysiology to therapeutic target in major depressive disorder[J]. Int J Mol Sci, 2022, 24(1): 133. doi:10.3390/ijms24010133
|
| [7] |
Leonard BE. Inflammation and depression: a causal or coincidental link to the pathophysiology[J]? Acta Neuropsychiatr, 2018, 30(1): 1-16. doi:10.1017/neu.2016.69
|
| [8] |
雷晶晶, 何乾超, 高玉广, 等. 基于cAMP/PKA/CREB/BDNF通路的中药治疗抑郁症的药理机制研究进展 [J]. 环球中医药, 2025(2):148-56.
|
| [9] |
Duman RS, Aghajanian GK. Synaptic dysfunction in depression: potential therapeutic targets[J]. Science, 2012, 338(6103): 68-72. doi:10.1126/science.1222939
|
| [10] |
肖智慧, 魏军平. 栀子豉汤的研究新进展[J]. 中国实验方剂学杂志, 2025, 31(18): 295-305.
|
| [11] |
刘朋良, 许二平, 康丽杰, 等. 栀子豉汤治疗抑郁症研究新进展[J]. 中华中医药学刊, 2024, 42(02):171-74. doi:10.13193/j.issn.1673-7717.2024.02.032
|
| [12] |
曹康迪, 胡帅航, 王 烁, 等. 栀子豉汤的研究进展 [J]. 中华中医药学刊, 2022, 40(06):182-85.
|
| [13] |
Tao WW, Yao GD, Yue QY, et al. 14-3-3ζ Plays a key role in the modulation of neuroplasticity underlying the antidepressant-like effects of Zhi-Zi-Chi-Tang[J]. Phytomedicine, 2023, 116: 154888. doi:10.1016/j.phymed.2023.154888
|
| [14] |
刘佳琳, 肠道菌群介导的栀子豉汤抗抑郁作用及配伍机制研究 [D]. 中国人民解放军海军军医大学, 2019.
|
| [15] |
曲书阅, 衡 霞, 戚懿予, 等. 栀子总环烯醚萜对抑郁模型小鼠神经递质的影响[J]. 中成药 2021, 43(4): 1022-27. doi:10.3969/j.issn.1001-1528.2021.04.037
|
| [16] |
陶伟伟, 白子君, 岳启予, 等. 栀子豉汤对慢性应激诱导的抑郁模型小鼠脑组织神经炎症和突触可塑性的影响[J]. 中医杂志, 2022, 63(11): 1073-9.
|
| [17] |
Chai C, Jin B, Yan YY, et al. Anti-depressant effect of Zhi-zi-Chi decoction on CUMS mice and elucidation of its signaling pathway[J]. J Ethnopharmacol, 2021, 266: 113283. doi:10.1016/j.jep.2020.113283
|
| [18] |
尹树铸, 昌盛元海丹. 栀子豉汤治疗抑郁症的研究进展 [J]. 吉林医药学院学报, 2020, 41(02):142-46.
|
| [19] |
Shen JL, Hao CY, Yuan SW, et al. Acupuncture alleviates CUMS-induced depression-like behaviors of rats by regulating oxidative stress, neuroinflammation and ferroptosis[J]. Brain Res, 2024, 1826: 148715. doi:10.1016/j.brainres.2023.148715
|
| [20] |
Liu S, Xu S, Wang Z, et al. Anti-depressant-like effect of sinomenine on chronic unpredictable mild stress-induced depression in a mouse model[J]. Med Sci Monit, 2018, 24: 7646-53. doi:10.12659/msm.908422
|
| [21] |
Xia J, Chen M, Shao H, et al. Inflammation and late-life depression: unraveling the complex relationship and potential therapeutic strategies[J]. Front Biosci: Landmark Ed, 2023, 28(12): 356. doi:10.31083/j.fbl2812356
|
| [22] |
Zhao XN, Cao FR, Liu Q, et al. Behavioral, inflammatory and neurochemical disturbances in LPS and UCMS-induced mouse models of depression[J]. Behav Brain Res, 2019, 364: 494-502. doi:10.1016/j.bbr.2017.05.064
|
| [23] |
Corrigan M, O’Rourke AM, Moran B, et al. Inflammation in the pathogenesis of depression: a disorder of neuroimmune origin[J]. Neuronal Signal, 2023, 7(2): NS20220054. doi:10.1042/ns20220054
|
| [24] |
O' Mahony SM, Clarke G, Borre YE, et al. Serotonin, tryptophan metabolism and the brain-gut-microbiome axis[J]. Behav Brain Res, 2015, 277: 32-48. doi:10.1016/j.bbr.2014.07.027
|
| [25] |
张若琳, 漆正堂, 刘微娜. 微生物-肠-脑轴视角下色氨酸代谢介导的运动抗抑郁机制研究进展 [J]. 中国运动医学杂志, 2023, 42(3):227-35. doi:10.3969/j.issn.1000-6710.2023.03.008
|
| [26] |
陈丽艳, 陈雨竹, 宓月光, 等. 栀子豉汤及其固体发酵菌质对CUMS大鼠抗抑郁作用对比研究[J]. 中国中药杂志, 2024, 46(19): 5044-51.
|
| [27] |
Hernández-Hernández OT, Martínez-Mota L, Herrera-Pérez JJ, et al. Role of estradiol in the expression of genes involved in serotonin neurotransmission: implications for female depression[J]. Curr Neuropharmacol, 2019, 17(5): 459-71. doi:10.2174/1570159x16666180628165107
|
| [28] |
Bian QY, Wang JM. Tryptophan hydroxylase 2 and tryptophan mediate depression by regulating serotonin levels[J]. AIP Publishing, 2022, 2511(1): 020006.
|
| [29] |
Kouba BR, de Araujo Borba L, Borges de Souza P, et al. Role of inflammatory mechanisms in major depressive disorder: from etiology to potential pharmacological targets[J]. Cells, 2024, 13(5): 423. doi:10.3390/cells13050423
|
| [30] |
陈玟璇, 康舒悦, 赵 荻, 等. 从中医辨证分型探讨中药复方防治抑郁症 [J]. 中药新药与临床药理, 2025, 36(3): 479-88. doi:10.19378/j.issn.1003-9783.2025.03.018
|
| [31] |
Xu Z, Rasteh AM, Dong A, et al. Identification of molecular targets of Hypericum perforatum in blood for major depressive disorder: a machine-learning pharmacological study[J]. Chin Med, 2024, 19(1): 141. doi:10.1186/s13020-024-01018-5
|
| [32] |
Albini M, Krawczun-Rygmaczewska A, Cesca F. Astrocytes and brain-derived neurotrophic factor (BDNF)[J]. Neurosci Res, 2023, 197: 42-51. doi:10.1016/j.neures.2023.02.001
|
| [33] |
Colucci-D'Amato L, Speranza L, Volpicelli F. Neurotrophic factor BDNF, physiological functions and therapeutic potential in depression, neurodegeneration and brain cancer[J]. Int J Mol Sci, 2020, 21(20): E7777. doi:10.3390/ijms21207777
|
| [34] |
Wang MY, Xie YH, Qin DD. Proteolytic cleavage of proBDNF to mBDNF in neuropsychiatric and neurodegenerative diseases[J]. Brain Res Bull, 2021, 166: 172-84. doi:10.1016/j.brainresbull.2020.11.005
|
| [35] |
Rana T, Behl T, Sehgal A, et al. Unfolding the role of BDNF as a biomarker for treatment of depression[J]. J Mol Neurosci, 2021, 71(10): 2008-21. doi:10.1007/s12031-020-01754-x
|
| [36] |
Wang CS, Kavalali ET, Monteggia LM. BDNF signaling in context: From synaptic regulation to psychiatric disorders[J]. Cell, 2022, 185(1): 62-76. doi:10.1016/j.cell.2021.12.003
|
| [37] |
Ampuero E, Luarte A, Flores FS, et al. The multifaceted effects of fluoxetine treatment on cognitive functions[J]. Front Pharmacol, 2024, 15: 1412420. doi:10.3389/fphar.2024.1412420
|
| [38] |
Talaee N, Azadvar S, Khodadadi S, et al. Comparing the effect of fluoxetine, escitalopram, and sertraline, on the level of BDNF and depression in preclinical and clinical studies: a systematic review[J]. Eur J Clin Pharmacol, 2024, 80(7): 983-1016. doi:10.1007/s00228-024-03680-y
|
| [39] |
García-García ML, Tovilla-Zárate CA, Villar-Soto M, et al. Fluoxetine modulates the pro-inflammatory process of IL-6, IL-1β and TNF‑α levels in individuals with depression: a systematic review and meta-analysis[J]. Psychiatry Res, 2022, 307: 114317. doi:10.1016/j.psychres.2021.114317
|